Covered recipient · General Payments record
CHRISTOPHER LEE PAIK
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$1,140.02
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $395.06 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $142.60 | 1 |
| Phathom Pharmaceuticals, Inc. | $124.82 | 2 |
| Abbott Laboratories | $51.49 | 3 |
| Novo Nordisk AS | $36.04 | 2 |
| Alnylam Pharmaceuticals Inc. | $24.59 | 1 |
| GlaxoSmithKline, LLC. | $15.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.09 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125121439 | CMS |
| Abbott Laboratories | $16.08 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125121441 | CMS |
| Abbott Laboratories | $19.32 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125121443 | CMS |
| Alnylam Pharmaceuticals Inc. | $24.59 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125849632 | CMS |
| GlaxoSmithKline, LLC. | $15.52 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116573958 | CMS |
| Janssen Pharmaceuticals, Inc | $142.60 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077957574 | CMS |
| Novo Nordisk Inc | $20.58 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097200435 | CMS |
| Novo Nordisk Inc | $15.46 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097027142 | CMS |
| Phathom Pharmaceuticals, Inc. | $80.78 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151105377 | CMS |
| Phathom Pharmaceuticals, Inc. | $44.04 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151105379 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.